Sort
30,917 grants matching “tumor microenvironment”
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$836,957Jyothi Rengarajan · Emory University · R01 · FY2021 · AI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma
$836,730Nasser Khaled Altorki · Weill Medical Coll Of Cornell Univ · UG3 · FY2019 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma
$836,730Nasser Khaled Altorki · Weill Medical Coll Of Cornell Univ · UG3 · FY2020 · CA
Gene Expression Profiling/Chronic Lymphocytic Leukemia
$836,258Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Development of a potent and selective oral ENPP1 inhibitor for oncology
$836,231Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2023 · CA
Clinical trials employing cancer vaccine combination therapies
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Lymphoma Disease Discovery and Definition
$835,502Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Cell-Matrix Interactions and Migration
$834,917Kenneth Manao Yamada · Dental & Craniofacial Research · Z01 · FY2007 · DE
Microenvironmental regulation of glioblastoma radiosensitivity
$834,513Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
$834,158Matthew J. Flick · Univ Of North Carolina Chapel Hill · U01 · FY2022 · HL
Angiogenesis and Tumor Growth
$833,984Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Vaccine and radiation for the therapy of human cancers
$833,695James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
$833,270Russell S Taichman · University Of Michigan At Ann Arbor · U54 · FY2015 · CA
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
$832,584David H. Gutmann · Washington University · U01 · FY2010 · CA
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$832,516Harriet M Kluger · Yale University · K12 · FY2021 · CA
Pancreatic Tumor Micro-environment Network
$831,601Surinder Kumar Batra · University Of Nebraska Medical Center · U54 · FY2011 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2019 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2021 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2020 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2018 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2022 · CA
TARGETING THE TUMOR MICROENVIRONMENT TO ENHANCE IMMUNOTHERAPY FOR SCLC
$828,591Duke University · · FY2025 · Defense Health Agency
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity
$828,044David Tuveson · Cold Spring Harbor Laboratory · U01 · FY2019 · CA
B cell determinants of EBV latency
$827,799Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · CA